Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.69, Iss.10, 2014-10, pp. : 759-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma

By Lee Su  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1540-1547

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma

By  

Journal of Digestive Diseases, Vol. 16, Iss. 9, 2015-09 ,pp. : 505-512

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selection of Patients with Hepatocellular Carcinoma for Sorafenib

By Abou-Alfa Ghassan K.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 4, 2009-04 ,pp. : 397-403

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Sorafenib: A Review of its Use in Advanced Hepatocellular Carcinoma

By Keating Gillian M.  

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 223-240

Adis International

Access to resources Recommend Favorite

Sorafenib: a guide to its use in advanced hepatocellular carcinoma

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite